• mail us help@24marketresearch.com
  • Int'l 1(332) 2424 294 (Int'l)

TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Inhaled Corticosteroid Market, Global Outlook and Forecast 2023-2030

Inhaled Corticosteroid Market, Global Outlook and Forecast 2023-2030

  • Category:Life Sciences
  • Published on : 18 November 2023
  • Pages :79
  • Formats:
  • Report Code:24MRES-7853338
Click for best price

Best Price: $2600

Asthma is a disease of the entire respiratory tract, including large, intermediate and small airways. Asthma led to inflammation and obstruction of respiratory tract. Patients have various treatment options for asthma, particularly for young and elderly patients. Hence this has led to significant interest on the part of the inhaler device which is easy to use. Inhaled corticosteroid is the most commonly used tool for the treatment of asthma. As with increasing pollution and increasing incidences of asthma, many companies are engaged in the development of new inhaler corticosteroid devices.
This report aims to provide a comprehensive presentation of the global market for Inhaled Corticosteroid, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Inhaled Corticosteroid. This report contains market size and forecasts of Inhaled Corticosteroid in global, including the following market information:
Global Inhaled Corticosteroid Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global Inhaled Corticosteroid Market Sales, 2018-2023, 2024-2030, (MT)
Global top five Inhaled Corticosteroid companies in 2022 (%)
The global Inhaled Corticosteroid market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
In terms of market value, North America will dominate the inhaler corticosteroid device market during the forecast period. Increasing incidences of life-threatening illness such as chronic obstructive pulmonary disease, asthma and many more are some of the factors which are responsible for the growth of the market during the forecast period.
We surveyed the Inhaled Corticosteroid manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Inhaled Corticosteroid Market, by Type, 2018-2023, 2024-2030 ($ Millions) & (MT)
Global Inhaled Corticosteroid Market Segment Percentages, by Type, 2022 (%)
Beclomethasone Dipropionate
Budesonide
Fluticasone Inhaler Powder
Mometasone
Others
Global Inhaled Corticosteroid Market, by Application, 2018-2023, 2024-2030 ($ Millions) & (MT)
Global Inhaled Corticosteroid Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinics
Respiratory Care Centers
Others
Global Inhaled Corticosteroid Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions) & (MT)
Global Inhaled Corticosteroid Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Inhaled Corticosteroid revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Inhaled Corticosteroid revenues share in global market, 2022 (%)
Key companies Inhaled Corticosteroid sales in global market, 2018-2023 (Estimated), (MT)
Key companies Inhaled Corticosteroid sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sumitomo
Pfizer
Novartis
Merck
Sanofi
Johnson and Johnson
GSK
AstraZeneca
Teijin
Glaxo's Advair
Amgen
Kos Pharmaceutical
Teva Pharmaceutical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Inhaled Corticosteroid, market overview.
Chapter 2: Global Inhaled Corticosteroid market size in revenue and volume.
Chapter 3: Detailed analysis of Inhaled Corticosteroid manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Inhaled Corticosteroid in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Inhaled Corticosteroid capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

TABLE OF CONTENTS

1 Introduction to Research & Analysis Reports
1.1 Inhaled Corticosteroid Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Inhaled Corticosteroid Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Inhaled Corticosteroid Overall Market Size
2.1 Global Inhaled Corticosteroid Market Size: 2022 VS 2030
2.2 Global Inhaled Corticosteroid Revenue, Prospects & Forecasts: 2018-2030
2.3 Global Inhaled Corticosteroid Sales: 2018-2030
3 Company Landscape
3.1 Top Inhaled Corticosteroid Players in Global Market
3.2 Top Global Inhaled Corticosteroid Companies Ranked by Revenue
3.3 Global Inhaled Corticosteroid Revenue by Companies
3.4 Global Inhaled Corticosteroid Sales by Companies
3.5 Global Inhaled Corticosteroid Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Inhaled Corticosteroid Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Inhaled Corticosteroid Product Type
3.8 Tier 1, Tier 2 and Tier 3 Inhaled Corticosteroid Players in Global Market
3.8.1 List of Global Tier 1 Inhaled Corticosteroid Companies
3.8.2 List of Global Tier 2 and Tier 3 Inhaled Corticosteroid Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Inhaled Corticosteroid Market Size Markets, 2022 & 2030
4.1.2 Beclomethasone Dipropionate
4.1.3 Budesonide
4.1.4 Fluticasone Inhaler Powder
4.1.5 Mometasone
4.1.6 Others
4.2 By Type - Global Inhaled Corticosteroid Revenue & Forecasts
4.2.1 By Type - Global Inhaled Corticosteroid Revenue, 2018-2023
4.2.2 By Type - Global Inhaled Corticosteroid Revenue, 2024-2030
4.2.3 By Type - Global Inhaled Corticosteroid Revenue Market Share, 2018-2030
4.3 By Type - Global Inhaled Corticosteroid Sales & Forecasts
4.3.1 By Type - Global Inhaled Corticosteroid Sales, 2018-2023
4.3.2 By Type - Global Inhaled Corticosteroid Sales, 2024-2030
4.3.3 By Type - Global Inhaled Corticosteroid Sales Market Share, 2018-2030
4.4 By Type - Global Inhaled Corticosteroid Price (Manufacturers Selling Prices), 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Inhaled Corticosteroid Market Size, 2022 & 2030
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Respiratory Care Centers
5.1.5 Others
5.2 By Application - Global Inhaled Corticosteroid Revenue & Forecasts
5.2.1 By Application - Global Inhaled Corticosteroid Revenue, 2018-2023
5.2.2 By Application - Global Inhaled Corticosteroid Revenue, 2024-2030
5.2.3 By Application - Global Inhaled Corticosteroid Revenue Market Share, 2018-2030
5.3 By Application - Global Inhaled Corticosteroid Sales & Forecasts
5.3.1 By Application - Global Inhaled Corticosteroid Sales, 2018-2023
5.3.2 By Application - Global Inhaled Corticosteroid Sales, 2024-2030
5.3.3 By Application - Global Inhaled Corticosteroid Sales Market Share, 2018-2030
5.4 By Application - Global Inhaled Corticosteroid Price (Manufacturers Selling Prices), 2018-2030
6 Sights by Region
6.1 By Region - Global Inhaled Corticosteroid Market Size, 2022 & 2030
6.2 By Region - Global Inhaled Corticosteroid Revenue & Forecasts
6.2.1 By Region - Global Inhaled Corticosteroid Revenue, 2018-2023
6.2.2 By Region - Global Inhaled Corticosteroid Revenue, 2024-2030
6.2.3 By Region - Global Inhaled Corticosteroid Revenue Market Share, 2018-2030
6.3 By Region - Global Inhaled Corticosteroid Sales & Forecasts
6.3.1 By Region - Global Inhaled Corticosteroid Sales, 2018-2023
6.3.2 By Region - Global Inhaled Corticosteroid Sales, 2024-2030
6.3.3 By Region - Global Inhaled Corticosteroid Sales Market Share, 2018-2030
6.4 North America
6.4.1 By Country - North America Inhaled Corticosteroid Revenue, 2018-2030
6.4.2 By Country - North America Inhaled Corticosteroid Sales, 2018-2030
6.4.3 US Inhaled Corticosteroid Market Size, 2018-2030
6.4.4 Canada Inhaled Corticosteroid Market Size, 2018-2030
6.4.5 Mexico Inhaled Corticosteroid Market Size, 2018-2030
6.5 Europe
6.5.1 By Country - Europe Inhaled Corticosteroid Revenue, 2018-2030
6.5.2 By Country - Europe Inhaled Corticosteroid Sales, 2018-2030
6.5.3 Germany Inhaled Corticosteroid Market Size, 2018-2030
6.5.4 France Inhaled Corticosteroid Market Size, 2018-2030
6.5.5 U.K. Inhaled Corticosteroid Market Size, 2018-2030
6.5.6 Italy Inhaled Corticosteroid Market Size, 2018-2030
6.5.7 Russia Inhaled Corticosteroid Market Size, 2018-2030
6.5.8 Nordic Countries Inhaled Corticosteroid Market Size, 2018-2030
6.5.9 Benelux Inhaled Corticosteroid Market Size, 2018-2030
6.6 Asia
6.6.1 By Region - Asia Inhaled Corticosteroid Revenue, 2018-2030
6.6.2 By Region - Asia Inhaled Corticosteroid Sales, 2018-2030
6.6.3 China Inhaled Corticosteroid Market Size, 2018-2030
6.6.4 Japan Inhaled Corticosteroid Market Size, 2018-2030
6.6.5 South Korea Inhaled Corticosteroid Market Size, 2018-2030
6.6.6 Southeast Asia Inhaled Corticosteroid Market Size, 2018-2030
6.6.7 India Inhaled Corticosteroid Market Size, 2018-2030
6.7 South America
6.7.1 By Country - South America Inhaled Corticosteroid Revenue, 2018-2030
6.7.2 By Country - South America Inhaled Corticosteroid Sales, 2018-2030
6.7.3 Brazil Inhaled Corticosteroid Market Size, 2018-2030
6.7.4 Argentina Inhaled Corticosteroid Market Size, 2018-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Inhaled Corticosteroid Revenue, 2018-2030
6.8.2 By Country - Middle East & Africa Inhaled Corticosteroid Sales, 2018-2030
6.8.3 Turkey Inhaled Corticosteroid Market Size, 2018-2030
6.8.4 Israel Inhaled Corticosteroid Market Size, 2018-2030
6.8.5 Saudi Arabia Inhaled Corticosteroid Market Size, 2018-2030
6.8.6 UAE Inhaled Corticosteroid Market Size, 2018-2030
7 Manufacturers & Brands Profiles
7.1 Sumitomo
7.1.1 Sumitomo Company Summary
7.1.2 Sumitomo Business Overview
7.1.3 Sumitomo Inhaled Corticosteroid Major Product Offerings
7.1.4 Sumitomo Inhaled Corticosteroid Sales and Revenue in Global (2018-2023)
7.1.5 Sumitomo Key News & Latest Developments
7.2 Pfizer
7.2.1 Pfizer Company Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Inhaled Corticosteroid Major Product Offerings
7.2.4 Pfizer Inhaled Corticosteroid Sales and Revenue in Global (2018-2023)
7.2.5 Pfizer Key News & Latest Developments
7.3 Novartis
7.3.1 Novartis Company Summary
7.3.2 Novartis Business Overview
7.3.3 Novartis Inhaled Corticosteroid Major Product Offerings
7.3.4 Novartis Inhaled Corticosteroid Sales and Revenue in Global (2018-2023)
7.3.5 Novartis Key News & Latest Developments
7.4 Merck
7.4.1 Merck Company Summary
7.4.2 Merck Business Overview
7.4.3 Merck Inhaled Corticosteroid Major Product Offerings
7.4.4 Merck Inhaled Corticosteroid Sales and Revenue in Global (2018-2023)
7.4.5 Merck Key News & Latest Developments
7.5 Sanofi
7.5.1 Sanofi Company Summary
7.5.2 Sanofi Business Overview
7.5.3 Sanofi Inhaled Corticosteroid Major Product Offerings
7.5.4 Sanofi Inhaled Corticosteroid Sales and Revenue in Global (2018-2023)
7.5.5 Sanofi Key News & Latest Developments
7.6 Johnson and Johnson
7.6.1 Johnson and Johnson Company Summary
7.6.2 Johnson and Johnson Business Overview
7.6.3 Johnson and Johnson Inhaled Corticosteroid Major Product Offerings
7.6.4 Johnson and Johnson Inhaled Corticosteroid Sales and Revenue in Global (2018-2023)
7.6.5 Johnson and Johnson Key News & Latest Developments
7.7 GSK
7.7.1 GSK Company Summary
7.7.2 GSK Business Overview
7.7.3 GSK Inhaled Corticosteroid Major Product Offerings
7.7.4 GSK Inhaled Corticosteroid Sales and Revenue in Global (2018-2023)
7.7.5 GSK Key News & Latest Developments
7.8 AstraZeneca
7.8.1 AstraZeneca Company Summary
7.8.2 AstraZeneca Business Overview
7.8.3 AstraZeneca Inhaled Corticosteroid Major Product Offerings
7.8.4 AstraZeneca Inhaled Corticosteroid Sales and Revenue in Global (2018-2023)
7.8.5 AstraZeneca Key News & Latest Developments
7.9 Teijin
7.9.1 Teijin Company Summary
7.9.2 Teijin Business Overview
7.9.3 Teijin Inhaled Corticosteroid Major Product Offerings
7.9.4 Teijin Inhaled Corticosteroid Sales and Revenue in Global (2018-2023)
7.9.5 Teijin Key News & Latest Developments
7.10 Glaxo's Advair
7.10.1 Glaxo's Advair Company Summary
7.10.2 Glaxo's Advair Business Overview
7.10.3 Glaxo's Advair Inhaled Corticosteroid Major Product Offerings
7.10.4 Glaxo's Advair Inhaled Corticosteroid Sales and Revenue in Global (2018-2023)
7.10.5 Glaxo's Advair Key News & Latest Developments
7.11 Amgen
7.11.1 Amgen Company Summary
7.11.2 Amgen Inhaled Corticosteroid Business Overview
7.11.3 Amgen Inhaled Corticosteroid Major Product Offerings
7.11.4 Amgen Inhaled Corticosteroid Sales and Revenue in Global (2018-2023)
7.11.5 Amgen Key News & Latest Developments
7.12 Kos Pharmaceutical
7.12.1 Kos Pharmaceutical Company Summary
7.12.2 Kos Pharmaceutical Inhaled Corticosteroid Business Overview
7.12.3 Kos Pharmaceutical Inhaled Corticosteroid Major Product Offerings
7.12.4 Kos Pharmaceutical Inhaled Corticosteroid Sales and Revenue in Global (2018-2023)
7.12.5 Kos Pharmaceutical Key News & Latest Developments
7.13 Teva Pharmaceutical
7.13.1 Teva Pharmaceutical Company Summary
7.13.2 Teva Pharmaceutical Inhaled Corticosteroid Business Overview
7.13.3 Teva Pharmaceutical Inhaled Corticosteroid Major Product Offerings
7.13.4 Teva Pharmaceutical Inhaled Corticosteroid Sales and Revenue in Global (2018-2023)
7.13.5 Teva Pharmaceutical Key News & Latest Developments
8 Global Inhaled Corticosteroid Production Capacity, Analysis
8.1 Global Inhaled Corticosteroid Production Capacity, 2018-2030
8.2 Inhaled Corticosteroid Production Capacity of Key Manufacturers in Global Market
8.3 Global Inhaled Corticosteroid Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Inhaled Corticosteroid Supply Chain Analysis
10.1 Inhaled Corticosteroid Industry Value Chain
10.2 Inhaled Corticosteroid Upstream Market
10.3 Inhaled Corticosteroid Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Inhaled Corticosteroid Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

LIST OF TABLES & FIGURES

List of Tables
Table 1. Key Players of Inhaled Corticosteroid in Global Market
Table 2. Top Inhaled Corticosteroid Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Inhaled Corticosteroid Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Inhaled Corticosteroid Revenue Share by Companies, 2018-2023
Table 5. Global Inhaled Corticosteroid Sales by Companies, (MT), 2018-2023
Table 6. Global Inhaled Corticosteroid Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Inhaled Corticosteroid Price (2018-2023) & (USD/MT)
Table 8. Global Manufacturers Inhaled Corticosteroid Product Type
Table 9. List of Global Tier 1 Inhaled Corticosteroid Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Inhaled Corticosteroid Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Inhaled Corticosteroid Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Global Inhaled Corticosteroid Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Inhaled Corticosteroid Revenue (US$, Mn), 2024-2030
Table 14. By Type - Global Inhaled Corticosteroid Sales (MT), 2018-2023
Table 15. By Type - Global Inhaled Corticosteroid Sales (MT), 2024-2030
Table 16. By Application ? Global Inhaled Corticosteroid Revenue, (US$, Mn), 2022 & 2030
Table 17. By Application - Global Inhaled Corticosteroid Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Inhaled Corticosteroid Revenue (US$, Mn), 2024-2030
Table 19. By Application - Global Inhaled Corticosteroid Sales (MT), 2018-2023
Table 20. By Application - Global Inhaled Corticosteroid Sales (MT), 2024-2030
Table 21. By Region ? Global Inhaled Corticosteroid Revenue, (US$, Mn), 2022 VS 2030
Table 22. By Region - Global Inhaled Corticosteroid Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Inhaled Corticosteroid Revenue (US$, Mn), 2024-2030
Table 24. By Region - Global Inhaled Corticosteroid Sales (MT), 2018-2023
Table 25. By Region - Global Inhaled Corticosteroid Sales (MT), 2024-2030
Table 26. By Country - North America Inhaled Corticosteroid Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Inhaled Corticosteroid Revenue, (US$, Mn), 2024-2030
Table 28. By Country - North America Inhaled Corticosteroid Sales, (MT), 2018-2023
Table 29. By Country - North America Inhaled Corticosteroid Sales, (MT), 2024-2030
Table 30. By Country - Europe Inhaled Corticosteroid Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Inhaled Corticosteroid Revenue, (US$, Mn), 2024-2030
Table 32. By Country - Europe Inhaled Corticosteroid Sales, (MT), 2018-2023
Table 33. By Country - Europe Inhaled Corticosteroid Sales, (MT), 2024-2030
Table 34. By Region - Asia Inhaled Corticosteroid Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Inhaled Corticosteroid Revenue, (US$, Mn), 2024-2030
Table 36. By Region - Asia Inhaled Corticosteroid Sales, (MT), 2018-2023
Table 37. By Region - Asia Inhaled Corticosteroid Sales, (MT), 2024-2030
Table 38. By Country - South America Inhaled Corticosteroid Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Inhaled Corticosteroid Revenue, (US$, Mn), 2024-2030
Table 40. By Country - South America Inhaled Corticosteroid Sales, (MT), 2018-2023
Table 41. By Country - South America Inhaled Corticosteroid Sales, (MT), 2024-2030
Table 42. By Country - Middle East & Africa Inhaled Corticosteroid Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Inhaled Corticosteroid Revenue, (US$, Mn), 2024-2030
Table 44. By Country - Middle East & Africa Inhaled Corticosteroid Sales, (MT), 2018-2023
Table 45. By Country - Middle East & Africa Inhaled Corticosteroid Sales, (MT), 2024-2030
Table 46. Sumitomo Company Summary
Table 47. Sumitomo Inhaled Corticosteroid Product Offerings
Table 48. Sumitomo Inhaled Corticosteroid Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 49. Sumitomo Key News & Latest Developments
Table 50. Pfizer Company Summary
Table 51. Pfizer Inhaled Corticosteroid Product Offerings
Table 52. Pfizer Inhaled Corticosteroid Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 53. Pfizer Key News & Latest Developments
Table 54. Novartis Company Summary
Table 55. Novartis Inhaled Corticosteroid Product Offerings
Table 56. Novartis Inhaled Corticosteroid Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 57. Novartis Key News & Latest Developments
Table 58. Merck Company Summary
Table 59. Merck Inhaled Corticosteroid Product Offerings
Table 60. Merck Inhaled Corticosteroid Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 61. Merck Key News & Latest Developments
Table 62. Sanofi Company Summary
Table 63. Sanofi Inhaled Corticosteroid Product Offerings
Table 64. Sanofi Inhaled Corticosteroid Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 65. Sanofi Key News & Latest Developments
Table 66. Johnson and Johnson Company Summary
Table 67. Johnson and Johnson Inhaled Corticosteroid Product Offerings
Table 68. Johnson and Johnson Inhaled Corticosteroid Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 69. Johnson and Johnson Key News & Latest Developments
Table 70. GSK Company Summary
Table 71. GSK Inhaled Corticosteroid Product Offerings
Table 72. GSK Inhaled Corticosteroid Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 73. GSK Key News & Latest Developments
Table 74. AstraZeneca Company Summary
Table 75. AstraZeneca Inhaled Corticosteroid Product Offerings
Table 76. AstraZeneca Inhaled Corticosteroid Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 77. AstraZeneca Key News & Latest Developments
Table 78. Teijin Company Summary
Table 79. Teijin Inhaled Corticosteroid Product Offerings
Table 80. Teijin Inhaled Corticosteroid Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 81. Teijin Key News & Latest Developments
Table 82. Glaxo's Advair Company Summary
Table 83. Glaxo's Advair Inhaled Corticosteroid Product Offerings
Table 84. Glaxo's Advair Inhaled Corticosteroid Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 85. Glaxo's Advair Key News & Latest Developments
Table 86. Amgen Company Summary
Table 87. Amgen Inhaled Corticosteroid Product Offerings
Table 88. Amgen Inhaled Corticosteroid Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 89. Amgen Key News & Latest Developments
Table 90. Kos Pharmaceutical Company Summary
Table 91. Kos Pharmaceutical Inhaled Corticosteroid Product Offerings
Table 92. Kos Pharmaceutical Inhaled Corticosteroid Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 93. Kos Pharmaceutical Key News & Latest Developments
Table 94. Teva Pharmaceutical Company Summary
Table 95. Teva Pharmaceutical Inhaled Corticosteroid Product Offerings
Table 96. Teva Pharmaceutical Inhaled Corticosteroid Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 97. Teva Pharmaceutical Key News & Latest Developments
Table 98. Inhaled Corticosteroid Production Capacity (MT) of Key Manufacturers in Global Market, 2021-2023 (MT)
Table 99. Global Inhaled Corticosteroid Capacity Market Share of Key Manufacturers, 2021-2023
Table 100. Global Inhaled Corticosteroid Production by Region, 2018-2023 (MT)
Table 101. Global Inhaled Corticosteroid Production by Region, 2024-2030 (MT)
Table 102. Inhaled Corticosteroid Market Opportunities & Trends in Global Market
Table 103. Inhaled Corticosteroid Market Drivers in Global Market
Table 104. Inhaled Corticosteroid Market Restraints in Global Market
Table 105. Inhaled Corticosteroid Raw Materials
Table 106. Inhaled Corticosteroid Raw Materials Suppliers in Global Market
Table 107. Typical Inhaled Corticosteroid Downstream
Table 108. Inhaled Corticosteroid Downstream Clients in Global Market
Table 109. Inhaled Corticosteroid Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Inhaled Corticosteroid Segment by Type in 2022
Figure 2. Inhaled Corticosteroid Segment by Application in 2022
Figure 3. Global Inhaled Corticosteroid Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Inhaled Corticosteroid Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Inhaled Corticosteroid Revenue, 2018-2030 (US$, Mn)
Figure 7. Inhaled Corticosteroid Sales in Global Market: 2018-2030 (MT)
Figure 8. The Top 3 and 5 Players Market Share by Inhaled Corticosteroid Revenue in 2022
Figure 9. By Type - Global Inhaled Corticosteroid Revenue, (US$, Mn), 2022 & 2030
Figure 10. By Type - Global Inhaled Corticosteroid Revenue Market Share, 2018-2030
Figure 11. By Type - Global Inhaled Corticosteroid Sales Market Share, 2018-2030
Figure 12. By Type - Global Inhaled Corticosteroid Price (USD/MT), 2018-2030
Figure 13. By Application - Global Inhaled Corticosteroid Revenue, (US$, Mn), 2022 & 2030
Figure 14. By Application - Global Inhaled Corticosteroid Revenue Market Share, 2018-2030
Figure 15. By Application - Global Inhaled Corticosteroid Sales Market Share, 2018-2030
Figure 16. By Application - Global Inhaled Corticosteroid Price (USD/MT), 2018-2030
Figure 17. By Region - Global Inhaled Corticosteroid Revenue, (US$, Mn), 2022 & 2030
Figure 18. By Region - Global Inhaled Corticosteroid Revenue Market Share, 2018 VS 2022 VS 2030
Figure 19. By Region - Global Inhaled Corticosteroid Revenue Market Share, 2018-2030
Figure 20. By Region - Global Inhaled Corticosteroid Sales Market Share, 2018-2030
Figure 21. By Country - North America Inhaled Corticosteroid Revenue Market Share, 2018-2030
Figure 22. By Country - North America Inhaled Corticosteroid Sales Market Share, 2018-2030
Figure 23. US Inhaled Corticosteroid Revenue, (US$, Mn), 2018-2030
Figure 24. Canada Inhaled Corticosteroid Revenue, (US$, Mn), 2018-2030
Figure 25. Mexico Inhaled Corticosteroid Revenue, (US$, Mn), 2018-2030
Figure 26. By Country - Europe Inhaled Corticosteroid Revenue Market Share, 2018-2030
Figure 27. By Country - Europe Inhaled Corticosteroid Sales Market Share, 2018-2030
Figure 28. Germany Inhaled Corticosteroid Revenue, (US$, Mn), 2018-2030
Figure 29. France Inhaled Corticosteroid Revenue, (US$, Mn), 2018-2030
Figure 30. U.K. Inhaled Corticosteroid Revenue, (US$, Mn), 2018-2030
Figure 31. Italy Inhaled Corticosteroid Revenue, (US$, Mn), 2018-2030
Figure 32. Russia Inhaled Corticosteroid Revenue, (US$, Mn), 2018-2030
Figure 33. Nordic Countries Inhaled Corticosteroid Revenue, (US$, Mn), 2018-2030
Figure 34. Benelux Inhaled Corticosteroid Revenue, (US$, Mn), 2018-2030
Figure 35. By Region - Asia Inhaled Corticosteroid Revenue Market Share, 2018-2030
Figure 36. By Region - Asia Inhaled Corticosteroid Sales Market Share, 2018-2030
Figure 37. China Inhaled Corticosteroid Revenue, (US$, Mn), 2018-2030
Figure 38. Japan Inhaled Corticosteroid Revenue, (US$, Mn), 2018-2030
Figure 39. South Korea Inhaled Corticosteroid Revenue, (US$, Mn), 2018-2030
Figure 40. Southeast Asia Inhaled Corticosteroid Revenue, (US$, Mn), 2018-2030
Figure 41. India Inhaled Corticosteroid Revenue, (US$, Mn), 2018-2030
Figure 42. By Country - South America Inhaled Corticosteroid Revenue Market Share, 2018-2030
Figure 43. By Country - South America Inhaled Corticosteroid Sales Market Share, 2018-2030
Figure 44. Brazil Inhaled Corticosteroid Revenue, (US$, Mn), 2018-2030
Figure 45. Argentina Inhaled Corticosteroid Revenue, (US$, Mn), 2018-2030
Figure 46. By Country - Middle East & Africa Inhaled Corticosteroid Revenue Market Share, 2018-2030
Figure 47. By Country - Middle East & Africa Inhaled Corticosteroid Sales Market Share, 2018-2030
Figure 48. Turkey Inhaled Corticosteroid Revenue, (US$, Mn), 2018-2030
Figure 49. Israel Inhaled Corticosteroid Revenue, (US$, Mn), 2018-2030
Figure 50. Saudi Arabia Inhaled Corticosteroid Revenue, (US$, Mn), 2018-2030
Figure 51. UAE Inhaled Corticosteroid Revenue, (US$, Mn), 2018-2030
Figure 52. Global Inhaled Corticosteroid Production Capacity (MT), 2018-2030
Figure 53. The Percentage of Production Inhaled Corticosteroid by Region, 2022 VS 2030
Figure 54. Inhaled Corticosteroid Industry Value Chain
Figure 55. Marketing Channels

SELECT A FORMAT

USD GBP EURO YEN Single User License
USD GBP EURO YEN Multi User License
USD GBP EURO YEN Corporate User License

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy
check discount